Literature DB >> 18376280

Secondary myelofibrosis in children.

Rahul Naithani1, Seema Tyagi, Ved Prakash Choudhry.   

Abstract

Myelofibrosis is a rare childhood myeloproliferative disorder. It has been reported as an associated complication of certain hematologic malignancies or as an isolated idiopathic process. We describe clinical course of 6 children diagnosed over 6 years. One child each responded well to steroid and treatment of the underlying condition. Three children died because of underlying conditions and 1 child was lost to follow up. A thorough search should be made for underlying disease when myelofibrosis is first diagnosed. Trephine biopsy though giving useful information, does not have a prognostic significance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376280     DOI: 10.1097/MPH.0b013e318161a9b8

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Idiopathic myelofibrosis in an infant.

Authors:  Rupali R Bavikar; Rajesh K Kulkarni; Ashok D Rathod; Meenal S Hastak
Journal:  Indian J Pediatr       Date:  2010-12-28       Impact factor: 1.967

2.  Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.

Authors:  Sofia Bota; Pedro Alves; Claudia Constantino; Raquel Maia
Journal:  BMJ Case Rep       Date:  2019-04-29

3.  Paediatric idiopathic myelofibrosis.

Authors:  Annapurna Saksena; Prerna Arora; Nita Khurana; G R Sethi; Tejinder Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-02       Impact factor: 0.900

Review 4.  Transient myelofibrosis with autoimmune pancytopenia: a case report.

Authors:  Tomohei Nakao; Takashi Fukushima; Takashi Shimizu; Toru Nanmoku; Satoshi Fujiyama; Ryoko Nakajima; Fujiko Fukushima; Masayuki Noguchi; Ryo Sumazaki
Journal:  Eur J Pediatr       Date:  2008-11-06       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.